company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4386000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4386000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4386000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2784000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6961000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9745000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5359000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5330000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,34000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5296000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5296000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5296000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23473000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23473000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 06:34:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5089000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5089000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5089000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2193000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7786000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9979000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4890000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,31000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4859000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,148000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4711000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4711000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4711000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25980000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25980000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 07:00:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2286000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4553000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6839000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6831000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,21000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6810000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-35000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6845000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6845000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6845000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27604000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27604000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27400000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 06:04:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2166000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4142000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6308000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6275000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6270000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-12000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6282000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6282000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6282000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27619000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27619000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27300000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 06:47:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1948000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3574000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5522000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5518000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5516000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,27000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5489000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5489000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5489000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27632000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27632000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27400000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 17:04:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1539000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7239000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7231000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1974000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1976000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5255000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,95000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,4548000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9708000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27500000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27500000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27623000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1689000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3813000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5502000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5493000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1321000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1317000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6810000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-76000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6886000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6886000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,160000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7046000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27637000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27637000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 07:47:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1527000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2328000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3855000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3848000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3846000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,39000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3807000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3807000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,279000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4086000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27644000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1599000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1997000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3596000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3567000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3565000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-26000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3591000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3591000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,2030000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5621000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37500000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37500000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38048000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 06:47:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2179000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2510000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4689000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4682000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4680000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-58000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4738000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4738000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,278000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5016000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45720000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:05:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2436000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3640000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6076000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6072000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6067000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-23000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6090000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6090000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,279000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6369000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43900000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43900000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43906000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2043000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6933000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8976000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8973000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8958000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8961000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8961000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,185000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9146000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76018000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 06:08:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2730000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5637000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8367000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8329000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8313000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8308000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8308000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,118000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8426000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84300000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84300000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82961000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 06:31:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2873000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6678000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9551000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9521000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9507000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,52000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9455000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9455000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,119000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9574000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84527000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 06:32:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3686000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8245000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11931000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11929000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11935000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,17000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11918000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-519000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12437000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-422000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-519000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11496000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,82200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,82200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82827000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3837000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8720000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12557000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12523000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,41000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12509000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,28000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12481000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12481000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12481000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105067000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:04:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3821000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8960000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12781000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12776000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,75000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,48000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12728000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,9000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12719000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12719000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12719000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,118002000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q2,2015-04-01,2015-06-30,2016-08-02 06:31:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4030000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7454000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11484000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11464000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,123000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,96000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11368000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11365000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11365000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11365000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,118248000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:02:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,190000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,190000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,190000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3708000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8565000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12273000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12083000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,118000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,94000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11989000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11990000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11990000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11990000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115092000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,294000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,294000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,294000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3916000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9296000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13212000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12918000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,120000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,97000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12821000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12823000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12823000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12823000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,116600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,121284000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:15:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,301000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,301000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,301000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3778000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10128000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13906000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13605000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,21000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,110000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,89000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13516000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,31000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13485000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13485000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13485000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,122600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,122600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,121323000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:55:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,323000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,323000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,323000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3907000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9393000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13300000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12977000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,90000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,71000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12906000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12903000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12903000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12903000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,129000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,129000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,121389000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:03:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15281000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15281000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15281000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3531000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11007000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14538000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,743000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,95000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,78000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,821000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,822000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,822000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,822000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15900000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15900000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15950000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,378000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,378000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,378000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4081000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11485000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15566000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15188000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,153000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,137000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15051000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-6000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15057000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15057000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15057000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,150600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,150600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,149100000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:15:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,187000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,187000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,187000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3888000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17891000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21779000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21592000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,144000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,131000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21461000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-10000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21471000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21471000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21471000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.15
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.15
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18676000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:06:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.15
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,164000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,164000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,164000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3919000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10912000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14831000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14667000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,159000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,148000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14519000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-11000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14530000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14530000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14530000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18704000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,173000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,173000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,173000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10365000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1128000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15193000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15020000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,118000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,108000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14912000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-14000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14926000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14926000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14926000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.76
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.76
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19675000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.76
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,255000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,255000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,255000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3481000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13556000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3498000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20535000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20280000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,211000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,204000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20076000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-19000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20095000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20095000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20095000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24800000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.81
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24800000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.81
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24879000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:16:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.81
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,163000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,163000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,163000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10880000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1583000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16463000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16300000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,271000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,267000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16033000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16031000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16031000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16031000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27200000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27133000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 08:51:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,145000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,145000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,145000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3984000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8860000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3836000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3017000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12025000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11880000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,277000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,277000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11603000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11605000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11605000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11605000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27000000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27175000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 16:06:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,99000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,99000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,99000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3955000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8545000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,95000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12595000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12496000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,330000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,330000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12166000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,16000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12150000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12150000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12150000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26600000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26601000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3143000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8102000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,131000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11376000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11376000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,404000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,404000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10972000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10974000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10974000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10974000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27400000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27400000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27676000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:16:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1448000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1448000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1448000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2895000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10024000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,45000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12964000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11516000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,339000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,339000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11177000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11176000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11176000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11176000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28700000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28461000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 08:51:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3023000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8359000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11387000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11387000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,249000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,249000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11138000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11133000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11133000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11133000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28500000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28500000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28847000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 16:06:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3420000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8368000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11788000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11788000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,158000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-598000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-440000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12228000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-11004000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23232000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23232000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23232000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19100000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.22
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19100000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.22
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28545000.0
Idera Pharmaceuticals Inc,IDRA,549300JLJLICQGQFXF87,0000861838,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.22
